Caris Life Sciences, Flatiron Health collaborate to increase access to comprehensive molecular testing

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

FDA has approved MI Cancer Seek for use as a companion diagnostic to identify patients with cancer who may benefit from treatment with targeted therapies.

November 08, 2024

Vol.50 No.42

In Brief

ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial

ECOG-ACRIN Cancer Research Group and Caris Life Sciences announced a multi-year research collaboration wherein Caris is pairing its genomic, transcriptomic, and proteomic profiling, advanced artificial intelligence and machine learning algorithms with ECOG-ACRIN’s research capabilities.

October 25, 2024

Vol.50 No.40

In Brief

Flatiron Health surpasses 1,000 research publications using RWD from its de-identified patient database

Flatiron Health announced a milestone of over 1,000 research publications utilizing Flatiron’s electronic health record-derived real world data.

October 18, 2024

Vol.50 No.39

In Brief

Michael Egger, Christopher Manz, Serena Phillips receive 2023 Real-World Data Impact Award from ACS, Flatiron

Michael EggerChristopher ManzSerena PhillipsMichael Egger, Christopher Manz, and Serena Phillips received the 2023 Real-World Data Impact Award from the American Cancer Society and Flatiron Health.

March 08, 2024

Vol.50 No.10

Real-world Evidence

Flatiron, Caris combine EHR, multi-omics data to support precision oncology

Two major cancer informatics companies—Flatiron Health and Caris Life Sciences—have created a partnership to generate combined biological and clinical real-world evidence datasets that can be used to inform the development of immuno-oncology agents and targeted cancer therapeutics.

January 26, 2024

Vol.50 No.04

By Matthew Bin Han Ong

Drugs & Targets

Caris, Flatiron partner to create real-world data offering

Caris Life Sciences and Flatiron Health have partnered to create a multimodal data offering to support and accelerate biopharmaceutical drug development and patient care.

January 12, 2024

Vol.50 No.02

Caris Life Sciences, Flatiron Health collaborate to increase access to comprehensive molecular testing

YOU MAY BE INTERESTED IN

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial

Flatiron Health surpasses 1,000 research publications using RWD from its de-identified patient database

Michael Egger, Christopher Manz, Serena Phillips receive 2023 Real-World Data Impact Award from ACS, Flatiron

Flatiron, Caris combine EHR, multi-omics data to support precision oncology

Caris, Flatiron partner to create real-world data offering

Renew today!

Subscriber content

Never miss an issue!

Login